Baseline characteristics of participants in the LANDMARC trial: A 3‐year, pan ‐india, prospective, longitudinal study to assess management and real‐world outcomes of diabetes mellitus

Author:

Das Ashok K.1ORCID,Mithal Ambrish2,Joshi Shashank3,Kumar K. M. Prasanna4,Kalra Sanjay5ORCID,Unnikrishnan A. G.6,Thacker Hemant7,Sethi Bipin8,Ghosh Romik9ORCID,Kanade Vaishali10,Nair Arjun9,Mohanasundaram Senthilnathan9,Menon Shalini K.9,Chodankar Deepa10,Salvi Vaibhav10,Trivedi Chirag10,Chatterjee Godhuli10,Chowdhury Subhankar11,Rais Nadeem12,Wangnoo Subhash K.13,Zargar Abdul H.14

Affiliation:

1. Pondicherry Institute of Medical Sciences (PIMS Puducherry India

2. Medanta ‐ The Medicity Gurgaon India

3. Lilavati Hospital Mumbai India

4. Centre for Diabetes and Endocrine Care Bengaluru India

5. Bharti Hospital Karnal India

6. Chellaram Diabetes Institute Pune India

7. Bhatia Hospital Mumbai India

8. Care Hospitals Hyderabad India

9. Sanofi India Ltd Mumbai India

10. Sanofi‐Synthelabo India Ltd Mumbai India

11. IPGME & R and SSKM Hospital Kolkata India

12. Chowpatti Medical Centre Mumbai India

13. Apollo Hospital Education and Research Foundation New Delhi India

14. Center for Diabetes & Endocrine Care Srinagar India

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Reference24 articles.

1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

2. International Diabetes Federation.Diabetes Atlas 9th edition. (2020a). Retrieved fromhttps://www.idf.org/our‐network/regions‐members/south‐east‐asia/welcome.html

3. International Diabetes Federation.Diabetes Atlas 9th edition. (2020b). Retrieved fromhttps://www.idf.org/our‐network/regions‐members/south‐east‐asia/diabetes‐in‐sea.html

4. International Diabetes Federation.Diabetes Atlas 9th edition. (2020c). Retrieved fromhttps://diabetesatlas.org/en/sections/demographic‐and‐geographic‐outline.html

5. Standards of Medical Care for Patients With Diabetes Mellitus

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3